InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by SIEGEL SUSAN E, Director. Director active across 3 companies, notably Illumina, INC.. Aggregated, 7 filings have been published. The latest transaction was filed on 25 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€79,843352 shares@ €226.82580.0004% mcap24.2% of flow
Common Stock
SEC:0001127602-22-015924:0·
04,155 shares0
Common Stock
SEC:0001567619-22-011886:0·
0524 shares0
Common Stock
SEC:0001209191-22-030710:0·
€124,809385 shares@ €324.17910.0006% mcap100.0% of flow
Common Stock
SEC:0001127602-21-018204·
€124,809385 shares@ €324.17910.0006% mcap37.9% of flow
Common Stock
SEC:0001127602-21-018204:0·
01,271 shares0
Common Stock
SEC:0001209191-21-035060·
01,271 shares0
Common Stock
SEC:0001209191-21-035060:0·
7 of 7 declarations
About SIEGEL SUSAN E
Susan E. Siegel is a Board Member at ALIGN TECHNOLOGY INC, ILLUMINA, INC., and NEVRO CORP. She provides her expertise in governance and strategy, contributing to guiding decisions and ensuring compliance. Her experience in the medical technology sector is a valuable asset to the board.
